DE2357389A1 - Pharmazeutische mittel fuer orale applikation, verfahren zu dessen herstellung und verwendung des in ihm enthaltenen glycerids zur erhoehung der gastrointestinalen absorption von arzneimitteln - Google Patents

Pharmazeutische mittel fuer orale applikation, verfahren zu dessen herstellung und verwendung des in ihm enthaltenen glycerids zur erhoehung der gastrointestinalen absorption von arzneimitteln

Info

Publication number
DE2357389A1
DE2357389A1 DE19732357389 DE2357389A DE2357389A1 DE 2357389 A1 DE2357389 A1 DE 2357389A1 DE 19732357389 DE19732357389 DE 19732357389 DE 2357389 A DE2357389 A DE 2357389A DE 2357389 A1 DE2357389 A1 DE 2357389A1
Authority
DE
Germany
Prior art keywords
glyceride
medium
pharmaceutical agent
fatty acids
acid
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
DE19732357389
Other languages
German (de)
English (en)
Inventor
Zenzo Harada
Masatoshi Hasegawa
Tadao Maeda
Toshio Nakamura
Takeshi Noguchi
Hiroshi Takenaka
Yoshiya Yamahira
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sumitomo Chemical Co Ltd
Original Assignee
Sumitomo Chemical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sumitomo Chemical Co Ltd filed Critical Sumitomo Chemical Co Ltd
Publication of DE2357389A1 publication Critical patent/DE2357389A1/de
Withdrawn legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/14—Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
DE19732357389 1972-11-18 1973-11-16 Pharmazeutische mittel fuer orale applikation, verfahren zu dessen herstellung und verwendung des in ihm enthaltenen glycerids zur erhoehung der gastrointestinalen absorption von arzneimitteln Withdrawn DE2357389A1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP11602172A JPS4971127A (fr) 1972-11-18 1972-11-18

Publications (1)

Publication Number Publication Date
DE2357389A1 true DE2357389A1 (de) 1974-05-22

Family

ID=14676810

Family Applications (1)

Application Number Title Priority Date Filing Date
DE19732357389 Withdrawn DE2357389A1 (de) 1972-11-18 1973-11-16 Pharmazeutische mittel fuer orale applikation, verfahren zu dessen herstellung und verwendung des in ihm enthaltenen glycerids zur erhoehung der gastrointestinalen absorption von arzneimitteln

Country Status (6)

Country Link
JP (1) JPS4971127A (fr)
BE (1) BE807312A (fr)
CA (1) CA1036072A (fr)
DE (1) DE2357389A1 (fr)
FR (1) FR2206943B1 (fr)
GB (1) GB1432784A (fr)

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4167558A (en) 1976-02-13 1979-09-11 Hoffmann-La Roche Inc. Novel sustained release tablet formulations
US4263313A (en) 1977-02-24 1981-04-21 Kali-Chemie Pharma Gmbh Topical pharmaceutical formulations, carrier compositions therefor, and preparation thereof
US4722941A (en) * 1978-06-07 1988-02-02 Kali-Chemie Pharma Gmbh Readily absorbable pharmaceutical compositions of per se poorly absorbable pharmacologically active agents and preparation thereof

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4202888A (en) * 1976-07-12 1980-05-13 Kali-Chemie Pharma Gmbh. Readily enterally absorbable pharmaceutical compositions of cardiac glycosides and preparation thereof
US4230702A (en) * 1978-01-09 1980-10-28 Kali-Chemie Pharma Gmbh Readily enterally absorbable pharmaceutical compositions of per se poorly enterally absorbable pharmacologically active agents
AT358530B (de) * 1978-04-25 1980-09-10 Plc Pharma Licences Stabilisierungsverfahren
NL7806048A (nl) * 1978-06-02 1979-12-04 Kali Chemie Pharma Gmbh Geneesmiddel met betere resorptie-eigenschappen en werkwijze voor de bereiding daarvan.
FR2500302B1 (fr) * 1981-02-25 1985-11-15 Negma Laboratoires Nouvelles compositions pharmaceutiques d'indometacine
JPS5877810A (ja) * 1981-11-01 1983-05-11 Taiho Yakuhin Kogyo Kk ポリグリセロ−ル不飽和脂肪酸エステルを含む経口薬剤組成物
US4525339A (en) * 1982-10-15 1985-06-25 Hoffmann-La Roche Inc. Enteric coated oral dosage form
JPS60153758A (ja) * 1984-01-23 1985-08-13 Kao Corp 油脂組成物
FR2569561B1 (fr) * 1984-08-30 1990-05-18 Oreal Composition stable d'anthraline dans des triglycerides d'acides gras satures d'origine vegetale ayant de 6 a 12 atomes de carbone
JP2537658B2 (ja) * 1987-04-13 1996-09-25 小野薬品工業株式会社 エステル類またはアミド類を有効成分として含有する新規な製剤
IE59934B1 (en) * 1987-06-19 1994-05-04 Elan Corp Plc Liquid suspension for oral administration
IL87219A0 (en) * 1987-08-07 1988-12-30 Abbott Lab Erythromycin formulations for oral administration
JP5666760B2 (ja) * 2005-03-31 2015-02-12 サントリーホールディングス株式会社 リグナン類化合物含有組成物
EP1930333B1 (fr) 2005-09-30 2014-11-05 Suntory Holdings Limited Méthode et appareillage pour l'élaboration d'une préparation riche en épisésamine
SG10201601998PA (en) * 2006-03-31 2016-04-28 Suntory Holdings Ltd Jp Compositions containing lignan-class compounds

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE567598A (fr) *

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4167558A (en) 1976-02-13 1979-09-11 Hoffmann-La Roche Inc. Novel sustained release tablet formulations
US4263313A (en) 1977-02-24 1981-04-21 Kali-Chemie Pharma Gmbh Topical pharmaceutical formulations, carrier compositions therefor, and preparation thereof
US4722941A (en) * 1978-06-07 1988-02-02 Kali-Chemie Pharma Gmbh Readily absorbable pharmaceutical compositions of per se poorly absorbable pharmacologically active agents and preparation thereof

Also Published As

Publication number Publication date
AU6254373A (en) 1975-05-15
FR2206943B1 (fr) 1977-09-02
BE807312A (fr) 1974-03-01
JPS4971127A (fr) 1974-07-10
CA1036072A (fr) 1978-08-08
GB1432784A (en) 1976-04-22
FR2206943A1 (fr) 1974-06-14

Similar Documents

Publication Publication Date Title
DE2357389A1 (de) Pharmazeutische mittel fuer orale applikation, verfahren zu dessen herstellung und verwendung des in ihm enthaltenen glycerids zur erhoehung der gastrointestinalen absorption von arzneimitteln
DE69910183T2 (de) Darmlösliche sprudelnde zusammensetzungen
DE60026144T2 (de) Benzamidformulierung mit histon-deacetylase-inhibitoraktivität
EP0004650B1 (fr) Usage de la 1,4-dihydro-2,6-diméthyl-4-(3-nitrophenyl)-3-beta-méthoxy ethylester-5-isopropylester-pyridine pour la préparation de médicaments ayant une activité cérébrale
DD142149A5 (de) Verfahren zur herstellung resorbierbarer galenischer kompositionen
DE2813480A1 (de) Arzneimittel-depotpraeparat vom mehrfacheinheitsdosen-typ
DE3490583T1 (de) Analgetische und anti-inflammatorische Mittel und Verfahren zu ihrer Verwendung
DE2950463A1 (de) Gallensaeuren enthaltende pharmazeutische zubereitung mit verlaengerter wirkungsdauer
DE2523998A1 (de) Pharmazeutische zubereitung fuer die behandlung der schizophrenie
DE69814850T2 (de) Paracetamol enthaltende schlickbare tablette
DE102004011512A1 (de) Pharmazeutische Zubereitung enthaltend Pimobendan
EP0185210B1 (fr) Utilisation de dérivés dipeptidiques pour la préparation de médicaments pour le traitement des malades atteints de sclérose latérale amyotrophique
EP0859626B1 (fr) Preparation pharmaceutique contenant une cyclosporine/des cyclosporines pour administration orale, et son procede de production
CH669523A5 (fr)
AT389226B (de) Verfahren zur herstellung einer analgetischen und antiinflammatorischen pharmazeutischen zubereitung
WO1999025332A1 (fr) Composition comprenant de l'acide azelaique
DE60033519T2 (de) Morphinsulfat enthaltende mikrogranulate, verfahren zu deren herstellung und pharmazeutische zusammensetzungen
DE1915798C3 (de) Antacidum-Präparat in Form einer wäßrigen Suspension
DE3226178A1 (de) Mittel enthaltend n-acetyl-p-aminophenol und ein antacidum
DE4404990C1 (de) Verfahren zur Herstellung eines sterilen Prednisolongels
DE19912436A1 (de) Ibuprofen-Lösung
EP0803254A1 (fr) Solutions alcooliques contenant de l'acide acétylsalicylique pour l'administration percutanée, leur utilisation dans la thérapie antithrombotique en tant que médicaments
DE1617593A1 (de) Verfahren zur Herstellung von Tabletten oder Pillen
DE69731981T2 (de) Neue verbesserte formulierung zur behandlung von thromboembolismus
DE3406837C2 (fr)

Legal Events

Date Code Title Description
OD Request for examination
8130 Withdrawal